Literature DB >> 21047903

Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.

P Scaffidi1, T Misteli.   

Abstract

Cancer is a disease of the genome. Whereas efforts to understand the molecular basis of cancer have in the past largely focused on the role of mutations, recent evidence points to a strong epigenetic component in tumorigenesis, and epigenetic defects have been linked to loss of cell cycle control and cell survival. Here, we discuss the possibility that epigenetic alterations may promote tumor formation by an alternative mechanism. We speculate that epigenetic changes in stem cells and somatic cells contribute significantly to carcinogenesis by disruption of cellular differentiation programs. Epigenetic interference and loss of cellular identity may be particularly relevant for the emergence of cancer stem cells.

Entities:  

Mesh:

Year:  2010        PMID: 21047903      PMCID: PMC6317079          DOI: 10.1101/sqb.2010.75.007

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  9 in total

1.  The myth of genetic enhancement.

Authors:  Philip M Rosoff
Journal:  Theor Med Bioeth       Date:  2012-06

2.  Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.

Authors:  Stacey M Frumm; Zi Peng Fan; Kenneth N Ross; Jeremy R Duvall; Supriya Gupta; Lynn VerPlank; Byung-Chul Suh; Edward Holson; Florence F Wagner; William B Smith; Ronald M Paranal; Christopher F Bassil; Jun Qi; Giovanni Roti; Andrew L Kung; James E Bradner; Nicola Tolliday; Kimberly Stegmaier
Journal:  Chem Biol       Date:  2013-05-23

Review 3.  Common features of chromatin in aging and cancer: cause or coincidence?

Authors:  Linda Zane; Vivek Sharma; Tom Misteli
Journal:  Trends Cell Biol       Date:  2014-08-04       Impact factor: 20.808

4.  Changes of bivalent chromatin coincide with increased expression of developmental genes in cancer.

Authors:  Stephan H Bernhart; Helene Kretzmer; Lesca M Holdt; Frank Jühling; Ole Ammerpohl; Anke K Bergmann; Bernd H Northoff; Gero Doose; Reiner Siebert; Peter F Stadler; Steve Hoffmann
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 5.  The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review.

Authors:  Hope S Rugo; Ira Jacobs; Shikhar Sharma; Frank Scappaticci; Thomas A Paul; Kristen Jensen-Pergakes; Gabriel G Malouf
Journal:  Adv Ther       Date:  2020-05-22       Impact factor: 3.845

6.  Epigenetics, nervous system tumors, and cancer stem cells.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Cancers (Basel)       Date:  2011-09-13       Impact factor: 6.639

7.  The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes.

Authors:  Elisabet Cuyàs; Juan Gumuzio; Sara Verdura; Joan Brunet; Joaquim Bosch-Barrera; Begoña Martin-Castillo; Tomás Alarcón; José Antonio Encinar; Ángel G Martin; Javier A Menendez
Journal:  Aging (Albany NY)       Date:  2020-03-18       Impact factor: 5.682

Review 8.  A Single Cell but Many Different Transcripts: A Journey into the World of Long Non-Coding RNAs.

Authors:  Enrico Alessio; Raphael Severino Bonadio; Lisa Buson; Francesco Chemello; Stefano Cagnin
Journal:  Int J Mol Sci       Date:  2020-01-01       Impact factor: 5.923

9.  Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis.

Authors:  Siddhant Kalra; Aayushi Mittal; Krishan Gupta; Vrinda Singhal; Anku Gupta; Tripti Mishra; Srivatsava Naidu; Debarka Sengupta; Gaurav Ahuja
Journal:  Commun Biol       Date:  2020-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.